First Study of Psilocybin Therapy in Low-Income Adults Shows Promising Results, Oregon-led research highlights new path for affordable, community-based mental health care for depression.

WHAT:
A Zoom media briefing to release findings from the first-ever study examining the effects of psilocybin-assisted therapy on low-income adults with depression. Conducted through Oregon’s state-regulated psilocybin program, the study also breaks ground as one of the first to assess group-based psychedelic therapy models. Oregon’s psilocybin therapy program has already helped more than 12,000 clients, and offers numerous opportunities for researchers to understand the real-world impacts of psychedelic healing.

WHY IT MATTERS:
As more states explore psychedelic-assisted therapies, this study provides early evidence that regulated psilocybin treatment can be safe, effective, and accessible for those underserved by the mental health system.

WHO:
Dr. Matthew Hicks (Principal Investigator), National University of Natural Medicine (NUMN)
Dr. Olivia Hicks, (Co-clinician), Synaptic Institute & National University of Natural Medicine
Heidi Pendergast, Oregon State Director, Healing Advocacy Fund Nathan Howard, Executive Director, Sheri Eckert Foundation